Pfizer and BioNTech to Co-Develop Potential COVID-19 Vaccine

Mary John Posted Mar 24, 2020


NEW YORK & MAINZ, Germany–(BUSINESS WIRE)–Pfizer Inc. (NYSE: PFE, “Pfizer”) and BioNTech SE (Nasdaq: BNTX, “BioNTech”) today announced that the companies have agreed to a letter of intent regarding the co-development and distribution (excluding China) of a potential mRNA-based coronavirus vaccine aimed at preventing COVID-19 infection. The companies have executed a Material

Read on

Vaccines, drugs: What will work against COVID-19?

Coronavirus Patient Treated With HIV Drugs Tests Negative In Kerala